ConductScience.org, home

Paper39228490

Therapeutic Gene Editing in Dyslipidemias.

Tamehri Zadeh SS and 1 other. Rev Cardiovasc Med, 2024. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Therapeutic Gene Editing in Dyslipidemias. Papers, record 39228490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39228490

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapeutic Gene Editing in Dyslipidemias.
PubMed
Journal
Rev Cardiovasc Med
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.36, provisional
iCite
Revised in PubMed
2024-09-06
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tamehri Zadeh SSSeyed Saeed
2Shapiro MDMichael D

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References92

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132951534Inactivation of ApoC3 by CRISPR/Cas9 Protects Against Atherosclerosis in Hamsters.Circ Res2020https://conductscience.org/library/papers/32951534PubMed
238385290ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization.Arterioscler Thromb Vasc Biol2024https://conductscience.org/library/papers/38385290PubMed
334940615CRISPR Gene Editing in Lipid Disorders and Atherosclerosis: Mechanisms and Opportunities.Metabolites2021https://conductscience.org/library/papers/34940615PubMed
427575716PCSK9: Regulation and Target for Drug Development for Dyslipidemia.Annu Rev Pharmacol Toxicol2017https://conductscience.org/library/papers/27575716PubMed
532097710CRISPR system: Discovery, development and off-target detection.Cell Signal2020https://conductscience.org/library/papers/32097710PubMed
61386087Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations.J Clin Invest1992https://conductscience.org/library/papers/1386087PubMed
723287722RNA-guided human genome engineering via Cas9.Science2013https://conductscience.org/library/papers/23287722PubMed
837862440Impact of poor medication adherence on clinical outcomes and health resource utilization in patients with hypertension and/or dyslipidemia: systematic review.Expert Rev Pharmacoecon Outcomes Res2024https://conductscience.org/library/papers/37862440PubMed
930504621ANGPTL3 Inhibitors - Their Role in Cardiovascular Disease Through Regulation of Lipid Metabolism.Circ J2019https://conductscience.org/library/papers/30504621PubMed
1024916110Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing.Circ Res2014https://conductscience.org/library/papers/24916110PubMed
1138031331First-in-human trial of PCSK9 gene editing therapy for lowering cholesterol: a new frontier in cardiovascular pharmacotherapy? News from AHA.Eur Heart J Cardiovasc Pharmacother2024https://conductscience.org/library/papers/38031331PubMed
1215017359Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity.Curr Opin Lipidol2004https://conductscience.org/library/papers/15017359PubMed
1320447543Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants.J Am Coll Cardiol2010https://conductscience.org/library/papers/20447543PubMed
1434183861Efficient C•G-to-G•C base editors developed using CRISPRi screens, target-library analysis, and machine learning.Nat Biotechnol2021https://conductscience.org/library/papers/34183861PubMed
1516909389Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote.Am J Hum Genet2006https://conductscience.org/library/papers/16909389PubMed
1624365577The pharmacogenomics of statins.Pharmacol Res2014https://conductscience.org/library/papers/24365577PubMed
1733609733Long-term stable reduction of low-density lipoprotein in nonhuman primates following in vivo genome editing of PCSK9.Mol Ther2021https://conductscience.org/library/papers/33609733PubMed
1829259529Genome Editing: Past, Present, and Future.Yale J Biol Med2017https://conductscience.org/library/papers/29259529PubMed
1919075393Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans.J Clin Invest2009https://conductscience.org/library/papers/19075393PubMed
2027096365Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.Nature2016https://conductscience.org/library/papers/27096365PubMed

See all 92 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42861404
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Based Genome Editing in Inherited Cardiovascular Diseases: Therapeutic Advances, Emerging Editing Platforms, and Translational Challenges.
Cureus2026https://conductscience.org/library/papers/42861404PubMed
42835632Rebuilding a protective allele with ADAR site-directed RNA editing.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42835632PubMed
42652126Lipoprotein(a) as a Cardiovascular Risk Factor: Clinical Significance and Therapeutic Perspectives.Biomedicines2026https://conductscience.org/library/papers/42652126PubMed
41304947Cardiovascular Therapeutics at the Crossroads: Pharmacological, Genetic, and Digital Frontiers.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41304947PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ANGPTL327329PubTator's text mininghttps://conductscience.org/library/genes/27329NCBI Gene
APOC3345PubTator's text mininghttps://conductscience.org/library/genes/345NCBI Gene
LDLR3949PubTator's text mininghttps://conductscience.org/library/genes/3949NCBI Gene
PCSK9255738PubTator's text mininghttps://conductscience.org/library/genes/255738NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39228490

GET https://conductscience.org/api/papers/v1/39228490/references?page=2